Literature DB >> 8503666

Growth and growth hormone secretion after bone marrow transplantation.

R Brauner1, M Fontoura, J M Zucker, A Devergie, J C Souberbielle, C Prevot-Saucet, J Michon, E Gluckman, C Griscelli, A Fischer.   

Abstract

This study analyses the growth and the growth hormone secretion of children given various conditioning protocols before bone marrow transplantation (BMT). Twenty nine children (14 boys, 15 girls) given BMT were classified according to their conditioning protocol: total body irradiation (TBI) given as a single exposure of 10 Grays (Gy, group I, 11 cases), or 8 Gy (group II, four cases), 12 Gy given as six fractionated doses (Group III, seven cases), or chemotherapy alone (group IV, seven cases). The arginine-insulin stimulated growth hormone peak, 2-7.5 years after BMT, was > 10 micrograms/l in all patients except four from group I (6.9-8.9 micrograms/l). A second growth hormone secretion evaluation was performed in 10 group I patients because of persistent low growth velocity despite a normal growth hormone peak. There were no significant changes in the mean (SEM) stimulated growth hormone peak (18.4 (2.2) v 20.1 (3.6) micrograms/l) at 3 (0.3) to 5.2 (0.6) years after BMT. The sleep growth hormone peaks and concentrations (n = 6) were normal. The mean cumulative height changes (SD) during the three years after BMT were: -1.4 (0.2) in group I, -0.1 (0.4) in group II, -0.4 (0.2) in group III, and 1.5 (0.5) in group IV; this was significant in groups I and IV. The final heights of two monozygotic twins (BMT donor and recipient) had differed by 17.5 cm, despite them both having normal growth hormone peaks and puberty. Eight patients, treated for congenital immune deficiency syndrome, were growth retarded at the time of BMT. Of these, only those conditioned by chemotherapy alone had significant catch up growth (2(0.6)SD) while those conditioned by a single Gy exposure did not (0(0.4)SD). It is concluded that the total radiation dose is critical for growth evolution, as is the fractionation schedule. For the TBI doses and the interval since BMT studied, there was no correlation between growth hormone peak and the height loss. The rapidity of decreased growth velocity after TBI and the comparison between the monozygotic twins suggest that radiation induced skeletal lesions are partly responsible for the decreased growth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503666      PMCID: PMC1029264          DOI: 10.1136/adc.68.4.458

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

Review 2.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

Review 3.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

4.  Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia.

Authors:  S M Willi; K Cooke; J Goldwein; C S August; J S Olshan; T Moshang
Journal:  J Pediatr       Date:  1992-05       Impact factor: 4.406

5.  Growth and growth hormone in children after bone marrow transplantation.

Authors:  B Borgström; P Bolme
Journal:  Horm Res       Date:  1988

6.  Increasing utilization of bone marrow transplantation.

Authors:  M M Bortin; A A Rimm
Journal:  Transplantation       Date:  1986-09       Impact factor: 4.939

7.  The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function.

Authors:  A D Leiper; R Stanhope; T Lau; D B Grant; H Blacklock; J M Chessells; P N Plowman
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

8.  Growth and development following marrow transplantation for leukemia.

Authors:  J E Sanders; S Pritchard; P Mahoney; D Amos; C D Buckner; R P Witherspoon; H J Deeg; K C Doney; K M Sullivan; F R Appelbaum
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

9.  Growth in children following irradiation for bone marrow transplantation.

Authors:  S Bushhouse; N K Ramsay; O H Pescovitz; T Kim; L L Robison
Journal:  Am J Pediatr Hematol Oncol       Date:  1989

10.  Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukemia.

Authors:  L Hovi; J Rajantie; M Perkkiö; K Sainio; I Sipilä; M A Siimes
Journal:  Bone Marrow Transplant       Date:  1990-03       Impact factor: 5.483

View more
  6 in total

Review 1.  Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. II: Deleterious consequences.

Authors:  T D Miale; S Sirithorn; S Ahmed
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

2.  Survival outcomes, hematologic complications and growth impairment after sequential chemoradiotherapy in intracranial NGGCTs: a retrospective study.

Authors:  Lei Wen; Juan Li; Mingyao Lai; Zhaoming Zhou; Qingjun Hu; Guanhua Deng; Changguo Shan; Ruyu Ai; Hainan Li; Ming Lu; Liang Zhang; Taihua Wu; Dan Zhu; Yuanyuan Chen; Longhua Chen; Linbo Cai; Cheng Zhou
Journal:  Strahlenther Onkol       Date:  2021-10-21       Impact factor: 3.621

3.  Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant.

Authors:  Hiroyuki Ishiguro; Yukiharu Yasuda; Hiromi Hyodo; Yuichiro Tomita; Takashi Koike; Tsuyoshi Shinagawa; Takashi Shimizu; Tsuyoshi Morimoto; Kinya Hattori; Masae Matsumoto; Hiroyasu Inoue; Hiromasa Yabe; Miharu Yabe; Osamu Shinohara; Shunichi Kato
Journal:  Clin Pediatr Endocrinol       Date:  2009-02-19

4.  Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.

Authors:  Y Belkacémi; F Pène; E Touboul; B Rio; V Leblond; N C Gorin; A Laugier; C Gemici; M Housset; M Ozsahin
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

Review 5.  Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors.

Authors:  Netanya I Pollock; Laurie E Cohen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-22       Impact factor: 5.555

6.  Endocrine complications after busulphan and cyclophosphamide based hematopoietic stem cell transplant: A single tertiary care centre experience.

Authors:  Abhay Gundgurthi; M K Garg; Velu Nair; Rajeev Pakhetra; Satyanarayan Das; Sanjeevan Sharma; Manoj K Dutta; Sandeep Kharb; Rajan Kapoor
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.